Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Adams

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Virology|February 28, 2002
Equine infectious anemia virus and the ubiquitin-proteasome systemDavid E Ott, Lori V Coren, Raymond C Sowder, et al.
Journal of the American Chemical Society|July 24, 2009
Regiospecific and stereoselective syntheses of (+/-) morphine, codeine, and thebaine via a highly stereocontrolled intramolecular 4 + 2 cycloaddition leading to a phenanthrofuran systemGilbert Stork, Ayako Yamashita, Julian Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2002
Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiaeMaitreya J Dunham, Hassan Badrane, Tracy Ferea, et al.
Stroke|April 3, 2004
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519Anthony J Williams, Rossana Berti, Jitendra R Dave, et al.
European Journal of Medicinal Chemistry|December 29, 2009
Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitorVincenzo Carbone, Marco Giglio, Roland Chung, et al.
Oncotarget|July 28, 2016
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cellsPeng Li, Sarah Diab, Mingfeng Yu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 25, 2002
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltrationAnthony J Williams, Sarah L Hale, John R Moffett, et al.
Investigational New Drugs|September 9, 2018
CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemiaMuhammed H Rahaman, Yingyi Yu, Longjin Zhong, et al.
Plant Science : an International Journal of Experimental Plant Biology|February 3, 2023
Candidate genes affecting stomatal density in rice (Oryza sativa L.) identified by genome-wide associationWatchara Phetluan, Samart Wanchana, Wanchana Aesomnuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell linesYi-He Ling, Leonard Liebes, Jian-Dong Jiang, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Virology|February 28, 2002
Equine infectious anemia virus and the ubiquitin-proteasome systemDavid E Ott, Lori V Coren, Raymond C Sowder, et al.
Journal of the American Chemical Society|July 24, 2009
Regiospecific and stereoselective syntheses of (+/-) morphine, codeine, and thebaine via a highly stereocontrolled intramolecular 4 + 2 cycloaddition leading to a phenanthrofuran systemGilbert Stork, Ayako Yamashita, Julian Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2002
Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiaeMaitreya J Dunham, Hassan Badrane, Tracy Ferea, et al.
Stroke|April 3, 2004
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519Anthony J Williams, Rossana Berti, Jitendra R Dave, et al.
European Journal of Medicinal Chemistry|December 29, 2009
Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitorVincenzo Carbone, Marco Giglio, Roland Chung, et al.
Oncotarget|July 28, 2016
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cellsPeng Li, Sarah Diab, Mingfeng Yu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 25, 2002
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltrationAnthony J Williams, Sarah L Hale, John R Moffett, et al.
Investigational New Drugs|September 9, 2018
CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemiaMuhammed H Rahaman, Yingyi Yu, Longjin Zhong, et al.
Plant Science : an International Journal of Experimental Plant Biology|February 3, 2023
Candidate genes affecting stomatal density in rice (Oryza sativa L.) identified by genome-wide associationWatchara Phetluan, Samart Wanchana, Wanchana Aesomnuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell linesYi-He Ling, Leonard Liebes, Jian-Dong Jiang, et al.
Pageof 7